{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:14:56Z","timestamp":1772165696898,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T00:00:00Z","timestamp":1713916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T00:00:00Z","timestamp":1713916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Grant-in-Aid for Scientific Research grant (C)","award":["22K07897"],"award-info":[{"award-number":["22K07897"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Idiopathic nephrotic syndrome (NS) presents as a hypercoagulable state, of which thromboembolism (TE) is a well-known life-threatening complication. Although TE is more likely to occur in venous vessels than arterial vessels, arterial TE is important because it may cause after-effects, including tissue necrosis and cerebral infarction (CI); therefore, prompt diagnosis and appropriate treatment are required. We report a pediatric NS case with multiple CIs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A 14-year-7-month-old Japanese girl was diagnosed with frequent relapsing NS, accompanied by headache and disturbance of consciousness during the second relapse. Brain magnetic resonance imaging (MRI) and four-dimensional computed tomography revealed multiple CIs, vasogenic edema, and cerebral venous sinus thrombosis (CVST). The patient had no underlying thrombophilia other than hypercoagulability due to NS and prednisolone (PSL), and no cardiac arrhythmia; however, a right-to-left shunt through the patent foramen ovale (PFO) was observed with the Valsalva maneuver by echocardiography. Therefore, we assumed that a potential cause of multiple CIs might be an embolic stroke, caused by thrombosis formed from a hypercoagulable state due to NS and PSL treatment and reached through PFO. Antiplatelet and anticoagulant therapies were administered for TE. She was treated with PSL and mycophenolate mofetil (MMF) for NS. Rituximab (RTX) was administered to prevent NS relapse after complete remission (CR). She underwent transcatheter PFO closure at age 14\u00a0years and 9\u00a0months because we considered that the right-to-left shunt through the PFO would be one of the risks for recurrent cerebral embolism when NS relapses. One year after the onset of CIs, an MRI indicated that the CVST had resolved, leaving no neurological sequelae due to CI; therefore, anticoagulant therapy was discontinued. And then she has been in CR for NS with only MMF therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>CI is a serious complication in patients with NS. The pathogenesis of multiple CIs is various, including right-to-left shunt through PFO, in addition to the hypercoagulability due to NS. It is important to investigate and manage underlying risks such as PFO, besides preventing the relapses of NS by aggressive treatments using MMF and RTX, in patients with NS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-024-03579-x","type":"journal-article","created":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T07:02:14Z","timestamp":1713942134000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pediatric frequent relapsing nephrotic syndrome with multiple cerebral infarctions accompanied by patent foramen ovale and cerebral venous sinus thrombosis: a case report"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1302-7512","authenticated-orcid":false,"given":"Zentaro","family":"Kiuchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eriko","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saaya","family":"Nunokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sawako","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Hosaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohito","family":"Kogure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masami","family":"Narita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,24]]},"reference":[{"issue":"5","key":"3579_CR1","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1055\/s-0033-1343887","volume":"39","author":"B Barbano","year":"2013","unstructured":"Barbano B, Gigante A, Amoroso A, Cianci R. Thrombosis in nephrotic syndrome. Semin Thromb Hemost. 2013;39(5):469\u201376.","journal-title":"Semin Thromb Hemost"},{"issue":"7","key":"3579_CR2","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1007\/s00467-020-04904-w","volume":"36","author":"N Hoseiny Nejad","year":"2021","unstructured":"Hoseiny Nejad N, Sharif AS, Otukesh H, Hosseini Shamsabadi R, Hekmat S, Sakhaei M. Determination of the value of albumin, anti-thrombin III, fibrinogen and D-dimer factors in the diagnosis of asymptomatic pulmonary embolism in patients with nephrotic syndrome. Pediatr Nephrol. 2021;36(7):1803\u20138.","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"3579_CR3","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3346\/jkms.2004.19.2.315","volume":"19","author":"YW Yun","year":"2004","unstructured":"Yun YW, Chung S, You SJ, Lee DK, Lee KY, Han SW, Jee HO, Kim HJ. Cerebral infarction as a complication of nephrotic syndrome: a case report with a review of the literature. J Korean Med Sci. 2004;19(2):315\u20139.","journal-title":"J Korean Med Sci"},{"issue":"1","key":"3579_CR4","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/s12882-023-03374-0","volume":"24","author":"X Han","year":"2023","unstructured":"Han X, Zhao P, Wang Z, Ji X, Zhao M. Acute lower extremity arterial thrombosis associated with nephrotic syndrome in adults: Case series and literature review. BMC Nephrol. 2023;24(1):318.","journal-title":"BMC Nephrol"},{"issue":"10","key":"3579_CR5","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1197\/j.aem.2007.06.040","volume":"14","author":"L Chen","year":"2007","unstructured":"Chen L, Kim Y, Santucci KA. Use of ultrasound measurement of the inferior vena cava diameter as an objective tool in the assessment of children with clinical dehydration. Acad Emerg Med. 2007;14(10):841\u20135.","journal-title":"Acad Emerg Med"},{"issue":"1","key":"3579_CR6","doi-asserted-by":"publisher","first-page":"54","DOI":"10.4103\/jpn.JPN_117_19","volume":"15","author":"S Dangi","year":"2020","unstructured":"Dangi S, Gwasikoti N. A case of deep cerebral venous thrombosis presenting like acute necrotizing encephalopathy. J Pediatr Neurosci. 2020;15(1):54\u20136.","journal-title":"J Pediatr Neurosci"},{"issue":"10","key":"3579_CR7","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1007\/s00234-022-02938-5","volume":"64","author":"J Kalita","year":"2022","unstructured":"Kalita J, Sachan A, Dubey AK, Jain N, Kumar S. A clinico-radiological study of deep cerebral venous thrombosis. Neuroradiology. 2022;64(10):1951\u201360.","journal-title":"Neuroradiology"},{"issue":"5","key":"3579_CR8","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1111\/j.1651-2227.1986.tb10294.x","volume":"75","author":"PF Hoyer","year":"1986","unstructured":"Hoyer PF, Gonda S, Barthels M, Krohn HP, Brodehl J. Thromboembolic complications in children with nephrotic syndrome. Risk and incidence Acta Paediatr Scand. 1986;75(5):804\u201310.","journal-title":"Risk and incidence Acta Paediatr Scand"},{"issue":"3","key":"3579_CR9","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.acra.2011.11.002","volume":"19","author":"LJ Zhang","year":"2012","unstructured":"Zhang LJ, Wang ZJ, Zhou CS, Lu L, Luo S, Lu GM. Evaluation of pulmonary embolism in pediatric patients with nephrotic syndrome with dual energy CT pulmonary angiography. Acad Radiol. 2012;19(3):341\u20138.","journal-title":"Acad Radiol"},{"issue":"3","key":"3579_CR10","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s00467-022-05739-3","volume":"38","author":"A Trautmann","year":"2023","unstructured":"Trautmann A, Boyer O, Hodson E, Bagga A, Gipson DS, Samuel S, et al. IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol. 2023;38(3):877\u2013919.","journal-title":"Pediatr Nephrol"},{"issue":"31","key":"3579_CR11","doi-asserted-by":"publisher","first-page":"e11642","DOI":"10.1097\/MD.0000000000011642","volume":"97","author":"F Gao","year":"2018","unstructured":"Gao F, Zhang J, Wang F, Xin X, Sha D. Cyclosporin A-related cerebral venous sinus thrombosis: A case report. Medicine. 2018;97(31):e11642.","journal-title":"Medicine"},{"issue":"10","key":"3579_CR12","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1007\/s00467-011-1886-x","volume":"26","author":"S Ito","year":"2011","unstructured":"Ito S, Kamei K, Ogura M, Sato M, Fujimaru T, Ishikawa T, et al. Maintenance therapy with mycophenolate mofetil after rituximab in pediatric patients with steroid-dependent nephrotic syndrome. Pediatr Nephrol. 2011;26(10):1823\u20138.","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"3579_CR13","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S1474-4422(13)70310-7","volume":"13","author":"RG Hart","year":"2014","unstructured":"Hart RG, Diener HC, Coutts SB, Easton JD, Granger CB, O\u2019Donnell MJ, et al. Cryptogenic Stroke\/ESUS International Working Group. Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol. 2014;13(4):429\u201338.","journal-title":"Lancet Neurol"},{"issue":"6","key":"3579_CR14","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1007\/s10072-011-0908-6","volume":"33","author":"P La Spina","year":"2012","unstructured":"La Spina P, Calabr\u00f2 RS, Casella C, Savica R, Granata F, Musolino R. Cerebellar infarction in a patient with cerebral vein thrombosis and patent foramen ovale: brain-to-brain embolism? Neurol Sci. 2012;33(6):1415\u20137.","journal-title":"Neurol Sci"},{"issue":"3","key":"3579_CR15","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1159\/000098471","volume":"57","author":"M Del Sette","year":"2007","unstructured":"Del Sette M, Dinia L, Gandolfo C. Brain-to-brain paradoxical embolism through patent foramen ovale after cerebral vein thrombosis. Eur Neurol. 2007;57(3):176\u20137.","journal-title":"Eur Neurol"},{"issue":"11","key":"3579_CR16","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1056\/NEJMoa1610057","volume":"377","author":"JL Saver","year":"2017","unstructured":"Saver JL, Carroll JD, Thaler DE, Smalling RW, MacDonald LA, Marks DS, et al. Long-term outcomes of patent foramen ovale closure or medical therapy after stroke. N Engl J Med. 2017;377(11):1022\u201332.","journal-title":"N Engl J Med"},{"issue":"11","key":"3579_CR17","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1056\/NEJMoa1707404","volume":"377","author":"L S\u00f8ndergaard","year":"2017","unstructured":"S\u00f8ndergaard L, Kasner SE, Rhodes JF, Andersen G, Iversen HK, Nielsen-Kudsk JE, et al. Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke. N Engl J Med. 2017;377(11):1033\u201342.","journal-title":"N Engl J Med"},{"issue":"11","key":"3579_CR18","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1056\/NEJMoa1705915","volume":"377","author":"J Mas","year":"2017","unstructured":"Mas J, Derumeaux G, Guillon B, Massardier E, Hosseini H, Mechtouff L, et al. Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke. N Engl J Med. 2017;377(11):1011\u201321.","journal-title":"N Engl J Med"},{"issue":"4","key":"3579_CR19","doi-asserted-by":"publisher","first-page":"385","DOI":"10.5603\/KP.a2015.0194","volume":"74","author":"M Wawrzy\u0144czyk","year":"2016","unstructured":"Wawrzy\u0144czyk M, Ga\u0142eczka M, Karwot B, Knop M, Bia\u0142kowski J. Efficiency of transcatheter patent foramen ovale closure in children after paradoxical embolism events. Kardiol Pol. 2016;74(4):385\u20139.","journal-title":"Kardiol Pol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03579-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-024-03579-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03579-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T07:06:22Z","timestamp":1713942382000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-024-03579-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,24]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3579"],"URL":"https:\/\/doi.org\/10.1186\/s12882-024-03579-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3986879\/v1","asserted-by":"object"}]},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,24]]},"assertion":[{"value":"25 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval is not applicable. Signed informed consent for participation was obtained directly from the legal guardians of the patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Signed informed consent for publication was obtained directly from legal guardians of the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"146"}}